New aspirin curbs 11 kinds of cancer, shrinks tumours
Washington: A new aspirin compound, the latest to join the armoury of drugs against cancer, has shown great promise in fighting and shrinking 11 different types of human cancer cells, without harming normal cells.
The new designer drug curbed the growth of cancer cells including that of colon, pancreatic, lung, prostate, breast, and leukemia, in the lab, according to a team from the Sophie Davis School of Biomedical Education of The City College of New York.
"The key components of this new compound are that it is very, very potent and yet it has minimal toxicity to the cells," said Khosrow Kashfi, associate professor at City College and principal study investigator, the journal Medicinal Chemistry Letters reports.
Prolonged use of aspirin is known to pose its own dangers: side-effects ranging from bleeding ulcers to kidney failure. To resolve this, researchers created a hybrid of two earlier formulations, which they have called "NOSH-aspirin."
They used the aspirin as a scaffold to support two molecules that have been shown to increase the drug`s safety and potency.
One arm of the hybrid aspirin releases nitric oxide (NO), which helps protect the stomach lining. The other releases hydrogen sulphide (H2S), which the researchers have previously shown enhances aspirin`s cancer-fighting ability, according to a City College statement.
The researchers suspected that the hybrid would be more effective than either of the two components alone to boost aspirin`s safety and power against cancer.
The aspirin compound also shrank human colon cancer tumours by 85 percent in live animals, again without adverse effects, according to another study by the City College researchers and colleague Kenneth Olson of Indiana University School of Medicine, South Bend.
"If what we have seen in animals can be translated to humans," said Kashfi, "it could be used in conjunction with other drugs to shrink tumors before chemotherapy or surgery."
Long the go-to drug for minor aches and pains, aspirin and other so-called non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen are known primarily for their ability to calm inflammation. Studies in the 1980s resolved a decades-old debate on the utility of a daily dose of aspirin to cut the risk of heart attack and stroke.
More recent studies tracking regular use of the drug and other NSAIDs demonstrated their remarkable ability to inhibit the growth of cancer.
"There`s a lot of data on aspirin showing that when taken on a regular basis, on average it reduces the risk of development of colon cancer by about 50 percent compared to nonusers," noted Kashfi.
These findings will be presented at the annual meeting of the American Association for Cancer Research in Chicago, from March 31 to April 4.
More from India
More from World
More from Sports
More from Entertaiment
- Rajasthan: Gujjars revive reservation agitation, block rail track
- J Jayalalithaa sworn-in as Chief Minister of Tamil Nadu
- Dr Subhash Chandra Show: Aspiring for more than what you have!
- ISIS to buy first nuclear weapon from Pak?
- Mumbai: CCTV captures assailant with gun at Film City
- Mathura SSP receives death threat letter, message for PM Modi
- BJP now central pole of Indian politics: Arun Jaitley
- Maharashtra FDA sends Maggi noodles for lab testing
- Watch: Fast N Facts @ 7:30pm
- Haridwar: Hotel Radisson Blu sealed for polluting Ganga
- Delhi: Two killed in road accident in New Ashok Nagar
- Reservation issue: Police register case against Bainsla, 20 others
- Girl in Punjab's Pathankot quit studies for fear of eve-teasing
- Zee Media exclusive chat with 'Welcome to Karachi' cast
- Special: Furious over rising water crisis, people take to the streets
- Goa Board SSC Exam Results 2015 announced
- ISIS close to buying nuclear weapon from Pakistan?
- Manohar Parrikar visits forward areas along LoC, reviews security situation
- Credibility of Prime Minister's Office restored by BJP, says Arun Jaitley
- ISIS justifies raping slave girls, says Michelle Obama is 'worth $40'
- There will be no delay in appointing CIC, CVC: Jitendra Singh
- IPL 2015 Final: Mumbai Indians vs Chennai Super Kings - Preview
- 'Unhappy' Celina Jaitley asks Sunny Leone to move out?
- Arvind Kejriwal to highlight AAP govt's 100 days work on Monday
- BJP's plan for one-year celebration: 200 big rallies, 5,000 public meetings
- CBSE Results 2015: 10th board exam results to be declared on May 27
- Heatwave leaves 153 dead in Telangana, Andhra Pradesh
- IPL 8 Final: We need to be at our best against Mumbai, says Michael Hussey
- Jayalalithaa returns as Tamil Nadu CM: As it happened
- Heatwave kills 223 in AP, Telangana, Chandrababu Naidu announces compensation; Delhi records hottest day